#United States #Robbins Geller #San Diego #Class Action #Neogen Corporation

Important Notice for Neogen Corporation Investors

Neogen Corporation (NASDAQ: NEOG) investors who have faced substantial losses have been informed of the opportunity to lead a class action lawsuit. Robbins Geller Rudman & Dowd LLP, a well-known law firm specializing in securities fraud, made the announcement regarding this legal action concerning the company's trading periods from January 5, 2023, to June 3, 2025.

The lead plaintiff for the case, titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, is being sought by September 16, 2025. This legal battle arises due to alleged misleading statements made by Neogen’s executives regarding the integration of their company with the Food Safety Division of 3M, which led investors to believe that the merger was progressing more positively than it truly was.

Background of the Allegations

In December 2021, Neogen Corporation announced a merger with 3M’s Food Safety Division, with the transaction closing in September 2022. The lawsuit claims that throughout the class period, Neogen and its executives failed to disclose critical issues related to this integration. Despite emerging inefficiencies from the merger, executives allegedly reassured investors without adequate transparency about these challenges.

Financial results released by Neogen reveal a troubling trend following the merger. On January 10, 2025, the company disclosed not only a significant GAAP net income loss due to a $461 million impairment charge related to the acquisition but also a reduction in their fiscal year 2025 revenue guidance. They admitted to internally controlled weaknesses regarding their financial reporting as of November 30, 2024, which they drew no attention to until publicly revealed.

Additionally, on April 9, 2025, Neogen reported a $11 million loss in their third quarter, including a worrying 3.4% decline in revenue, a trend attributed to ongoing integration issues. The announcement of CEO John Adent stepping down created further panic, contributing to a significant fall in stock price by 28%. This dramatic shift raises serious concerns from investors regarding the management’s competency and transparency.

Investor Action

Investors impacted by these developments are encouraged to seek appointment as lead plaintiff, which allows them to lead the charge in this class action against Neogen Corporation. As highlighted, being a lead plaintiff holds substantial importance but does not affect the ability of all investors to share in possible recoveries from the lawsuit.

Robbins Geller is calling interested investors who meet the criteria to provide their information through their dedicated platform. Moreover, the firm has secured more than $2.5 billion for investors in various related securities cases historically, which underlines their capability and commitment towards investor protection.

Conclusion

This legal notice represents a critical juncture for Neogen Corporation investors. With deadlines looming, affected parties are urged to act swiftly to ensure their voices are heard. The forthcoming class action lawsuit will serve not just as a means of potential financial restitution, but also as a vital step towards accountability for the executives at Neogen Corporation. If you believe you have been affected, further guidance can be received from the Robbins Geller law firm, or through their official page regarding this legal matter.

Contact: Robbins Geller Rudman & Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
[email protected]